Compare CIO & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIO | SOPH |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | Canada | Switzerland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.5M | 330.4M |
| IPO Year | 2014 | 2021 |
| Metric | CIO | SOPH |
|---|---|---|
| Price | $6.96 | $4.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 500.6K | 103.6K |
| Earning Date | 02-19-2026 | 11-04-2025 |
| Dividend Yield | ★ 4.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $163,795,000.00 | $73,297,000.00 |
| Revenue This Year | $0.32 | $18.32 |
| Revenue Next Year | $3.20 | $15.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 13.66 |
| 52 Week Low | $4.19 | $2.58 |
| 52 Week High | $7.01 | $5.30 |
| Indicator | CIO | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 60.81 | 52.40 |
| Support Level | $6.94 | $4.63 |
| Resistance Level | $6.97 | $4.95 |
| Average True Range (ATR) | 0.03 | 0.28 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 89.47 | 28.95 |
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.